Published in Medical Letter on the CDC and FDA, October 1st, 2000
The work is the first application of a novel analytical tool announced by the same core group of researchers last fall. Other important applications promise to follow, they indicate.
"Periods of great discovery in science are almost always preceded by the development of new tools," writes Prof. Matthew A. Nugent of Boston University in the September 12, 2000, issue of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.